Search research articles
Contact Us
Filters
Showing results (141-150 of 172) with videos related to
Page
of 18
Sort By:
Cancers
|
August 29, 2024
Pathological Features Associated with Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors
Salvador Rodriguez Franco, Sumaya Abdul Ghaffar, Ying Jin, et al.
Cancers
|
August 9, 2020
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
Nabanita Mukherjee, Carol M Amato, Jenette Skees, et al.
Immunohorizons
|
February 20, 2020
High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell Changes
Jessica S W Borgers, Richard P Tobin, Victoria M Vorwald, et al.
The Journal of Investigative Dermatology
|
May 25, 2012
Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance
Yuchun Luo, Lixia Z Ellis, Katiuscia Dallaglio, et al.
Molecular & Cellular Oncology
|
August 31, 2023
Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma
Akshay Pratap, Andrea Qualman, Hedlund Garrett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial
Jessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
Annals of Surgical Oncology
|
June 7, 2023
Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison with Historical Controls
Anna K Gergen, Christina M Stuart, Sara Byers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 29, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial
Jessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
Cancer Immunology Research
|
August 30, 2017
Antigen-Presenting Intratumoral B Cells Affect CD4<sup>+</sup> TIL Phenotypes in Non-Small Cell Lung Cancer Patients
Tullia C Bruno, Peggy J Ebner, Brandon L Moore, et al.
Annals of Surgical Oncology
|
June 9, 2023
ASO Author Reflections: Gastric Ischemic Preconditioning Prior to Esophagectomy: Laparoscopic Gastric Ischemic Preconditioning
Christina M Stuart, Anna K Gergen, Sara Byers, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 172) with videos related to
Sort By:
Page
of 18
Cancers
|
August 29, 2024
Pathological Features Associated with Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors
Salvador Rodriguez Franco, Sumaya Abdul Ghaffar, Ying Jin, et al.
Cancers
|
August 9, 2020
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
Nabanita Mukherjee, Carol M Amato, Jenette Skees, et al.
Immunohorizons
|
February 20, 2020
High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell Changes
Jessica S W Borgers, Richard P Tobin, Victoria M Vorwald, et al.
The Journal of Investigative Dermatology
|
May 25, 2012
Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance
Yuchun Luo, Lixia Z Ellis, Katiuscia Dallaglio, et al.
Molecular & Cellular Oncology
|
August 31, 2023
Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma
Akshay Pratap, Andrea Qualman, Hedlund Garrett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial
Jessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
Annals of Surgical Oncology
|
June 7, 2023
Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison with Historical Controls
Anna K Gergen, Christina M Stuart, Sara Byers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 29, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial
Jessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
Cancer Immunology Research
|
August 30, 2017
Antigen-Presenting Intratumoral B Cells Affect CD4<sup>+</sup> TIL Phenotypes in Non-Small Cell Lung Cancer Patients
Tullia C Bruno, Peggy J Ebner, Brandon L Moore, et al.
Annals of Surgical Oncology
|
June 9, 2023
ASO Author Reflections: Gastric Ischemic Preconditioning Prior to Esophagectomy: Laparoscopic Gastric Ischemic Preconditioning
Christina M Stuart, Anna K Gergen, Sara Byers, et al.
Page
of 18